跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Imaglif - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Imaglif
Approved
STANDARD
Imaglif
Exemed Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1f991d4613360584
Company
Exemed Pharmaceuticals
Type
Standard
Approval Details
Approval Id
1f991d4613360584
Drug Approval Philippines Name
Imaglif
Product Name
Imaglif
Registration Number
DRP-16372
Brand Name
Imaglif
Generic Name
Empagliflozin
Dosage Form
Film Coated Tablet
Dosage Strength
25 mg
Manufacturer
Exemed Pharmaceuticals
Importer
AMB HK Enterprises Inc.
Distributor
AMB HK Enterprises Inc.
Company Detail Path
/organization/exemed-pharmaceuticals
Issuance Date
20 February 2025
Expiry Date
20 February 2030
Pharmacologic Category
Sodium-glucose co-transporter 2 (SGLT2) inhibitor
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1f991d4613360584
Type
Standard
Back to Philippines FDA Approvals